All stock lists
Ellington Credit Company (New York Stock Exchange:EARN)
US · Delayed Price · Currency is USD
Financial Services · Asset Management
$2.45-$0.71 (-22.47%)
Market cap
$96.3M
Insider Score
Health Score
Analyst consensus
Listed since
May 1, 2013
Website
Insider Score
––Not scored
EARN Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Weak
From EARN’s reported statements · Q3 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $49.4M
- Net income
- -$37.3M
- Net margin
- -75.6%
Leverage7 / 20
Heavily indebted for what it earns.
- Total debt
- $202.1M
- Cash
- $19.9M
- Debt / equity
- 1.27
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $19.9M
- Current liabilities
- $148.1M
- Current ratio
- 0.13
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $182.1M
- Free cash flow
- $182.1M
- FCF margin
- 368.5%
Dilution & runway9 / 20
Some dilution over the past year.
- Shares outstanding
- 39.5M
- Share growth (1y)
- 13.3%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
EARN Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $10.90 M | $11.82 M | $12.34 M | $14.34 M | $15.41 M | $11.90 M |
| Revenue Growth (YoY) | -29.25 % | -0.69 % | 1239.63 % | 111.21 % | -5.94 % | 3.39 % |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $10.90 M | $11.82 M | $12.34 M | $14.34 M | $15.41 M | $11.90 M |
| SG&A Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $3.03 M | -$3.51 M | $40.03 M | $33.07 M | $9.17 M | -$21.00 K |
| Operating Income | $7.87 M | $15.32 M | -$27.70 M | -$18.73 M | $6.24 M | $11.92 M |
| Pretax Income | $3.67 M | $12.32 M | -$32.27 M | -$21.07 M | $4.28 M | $10.21 M |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $3.67 M | $12.32 M | -$32.27 M | -$21.07 M | $4.28 M | $10.21 M |
| EPS (Basic) | $0.09 | $0.33 | -$0.86 | -$0.56 | $0.12 | $0.29 |
| EPS (Diluted) | $0.09 | $0.33 | -$0.86 | -$0.56 | $0.12 | $0.29 |
| Shares Outstanding | 39.46 M | 37.63 M | 37.58 M | 37.57 M | 34.81 M | 34.81 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
